Structure Therapeutics Inc. American Depositary Shares (GPCR) News
Latest headlines that mention GPCR, newest first · each headline opens the original publisher
- Last price
- $22.01
- Day change
- -3.80%
- Next earnings
- 2026-11-05
GPCR headlines
latest coverageStructure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary conditions.
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
This clinical-stage biotech develops oral therapeutics for chronic diseases, targeting large global markets with unmet medical needs.
GPCR news alerts
Get an alert by email or push when a new headline mentions GPCR.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.